The Most Comprehensive Insight in Cancer Genomes: New Discoveries

Peter has a PhD in cancer bioinformatics and is passionate about applying and developing different genomic and bioinformatic methods to better understand the cancer genome to improve patient treatment. Currently, working as a Research Fellow in the Faculty of Medical and Health Science at the University of Auckland, he collaborates with several different researchers, clinicians and oncologists to study the genomic landscape of different cancer types. It is hoped that this work can identify biomarkers for use in clinical diagnosis to improve patient care.

Ayako Suzuki is an associate professor at the University of Tokyo who graduated from Graduate School of Frontier Sciences, the University of Tokyo with a Ph.D. in 2015. She is currently working on long-read sequencing of lung cancer genomes to characterize complicated mutation patterns of cancer genomes in collaboration with National Cancer Center, Japan. She is also conducting multi-layered sequencing analysis for elucidating epigenomic and transcriptomic aberrations in cancer cells.

Olivier holds a PhD in Molecular Biology and did a postdoc in Molecular Medicine at the University of South Florida. Since then, he held different commercial roles in genomics companies and has been at Oxford Nanopore for 6 years. He is now the associate director for Oncology at Oxford Nanopore Diagnostics with the aim to transform healthcare through real-time genomics.